Navigation Links
Chief Medical Officers in Biotechs Finally Have Their Own Conference

New York, New York (PRWEB) January 31, 2013

For the first time, Chief Medical Officers at biotechs will have their own conference thanks to the idea from Dr Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive Director of The Conference Forum, the organizer of the event says, “We are grateful to Dr Stoner’s idea for the conference and her insights into the unique challenges CMOs face every day at small to mid-size biotechs.”    

The Chief Medical Officer Summit takes place in Boston on May 6-7, 2013 and is dedicated to accomplishing two goals:

1. To bring together CMO executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital, working and meeting with investors and strategsing for appropriate exits.
2. To create a network of CMOs from small to mid size life science companies to share ideas, solutions and support.

Dr Steven Zelenkofske, CMO & SVP Clinical and Medical Affairs, Regado Biosciences and advisor to the program remarked, "I am excited about this conference and think it is very much needed."

Event Details: May 6-7, Boston, MA
The event organizers are offering a 10% discount with code CMOE and a pre-early bird rate before 3/1. Click here to register.

Program Overview and Agenda are available at
Questions, please email service(at)theconferenceforum(dot)org

Speaking Faculty:
Jodi Black, PhD, Deputy Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, NIH
Mark Corrigan, MD, President & CEO, Zalicus
Anthony Coyle, PhD, VP & CSO, Centers for Therapeutic Innovation, Pfizer
Daniel Curran, MD, VP, Corporate Development, Millennium, Takeda Oncology
Greg Fiore, MD, CMO, The Medicines Company
Ken Getz, MBA, Senior Research Fellow, Tufts
Sheila Gujrathi, MD, CMO, Receptos
M. Scott Harris, MD, CMO, Avaxia Biologics; Principal, Middleburg Consultants; and Clinical Professor of Medicine, Georgetown University School of Medicine
Eric Hedrick, MD, CMO, Epizyme
Karin Hehenberger, MD, PhD, Executive Vice President & CMO, Coronado Biosciences
Dennis Kim, MD, MBA, CMO, Zafgen
Chris Kiritsy, MBA, President & CEO, Arisaph
Lori Kunkel, MD, CMO, Pharmacyclics
Tyler Martin, MD, President, CMO & Director, Dynavax Technologies
Robert Pyke, MD, PhD, CMO, S1 Biopharma
Jim Roach, MD, CMO & Senior Vice President, Development, Momenta Pharmaceuticals
Oscar Segurado, MD, PhD, CMO, Crescendo Bioscience
Jeffrey Sherman, MD, FACP, CMO & Executive Vice President, Development, Manufacturing, and Regulatory Affairs, Horizon Pharma
Greg Simon, CEO, Poliwogg
Elizabeth Stoner, MD, Managing Director, MPM Capital
Mary Szela, MBA, Senior Vice President, Pharmaceutical Operations, Abbott Laboratories
Santosh Vetticaden, MD, PhD, CMO, ADVENTRX Pharmaceuticals
Nancy Wetherbee, MBA, ORBIT Director, Tufts Medical Center
Steven Zelenkofske, DO, FACC, CMO & Senior Vice President, Clinical and Medical Affairs, Regado Bioscience

About The Conference Forum:
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
2. Elsevier Welcomes New Editor-in-Chief for European Urology
3. Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
4. Mobility and Big Data Analytics Provider NuWare Announces the Appointment of Rohit Shyam as Chief Strategy & Marketing Officer
5. Dr. Gil Ben-Menachem appointed Chief Executive Officer of OphthaliX Inc.
6. TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
7. T1D Exchange Announces Appointment of Dana Ball as Chief Executive Officer
8. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer
9. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
10. PathoGenetix Names Ann Merrifield as Chief Executive Officer and Prepares to Launch Unique Bacterial Identification Technology
11. Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012
Post Your Comments:
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... ... Parallel 6 , the leading software as a service (SaaS) provider ... Patient Encounter CONSULT module which enables both audio and video telemedicine communication between the ... the CONSULT module, patients and physicians can schedule a face to face virtual patient ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
Breaking Biology Technology:
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
(Date:3/22/2016)... , PROVO and ... -- Newborn Screening Ontario (NSO), which operates the highest ... for molecular testing, and Tute Genomics and UNIConnect, leaders ... technology respectively, today announced the launch of a project ... sequencing (NGS) testing panel. NSO has ...
Breaking Biology News(10 mins):